RxDoctor Payments Data

Maci Kelley

Family · Greeneville, TNNPI 1942962519

Payments from drug & device makers

$3,559in general payments, 2019–2025

Across 241 payments — averaging $14.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$776
  • Novo Nordisk$561
  • Otsuka America Pharmaceutical, Inc.$452
  • GSK$238
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$155
  • Pfizer$150
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$3,559100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,559 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$12,839
Medicare patients
69
Services billed
219

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin17$18,338
MounjaroTirzepatide15$18,187
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$16,781
EliquisApixaban14$15,224
Dexlansoprazole DrDexlansoprazole12$1,910
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,218
Albuterol Sulfate HfaAlbuterol Sulfate62$1,014
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$907
Omeprazole33$749
FenofibrateFenofibrate Nanocrystallized28$672
Ultra-Fine Nano Pen NeedlePen Needle, Diabetic11$670
Gabapentin45$572
Montelukast Sodium72$522
Levothyroxine Sodium47$438
Atorvastatin Calcium63$437

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$109$18,33817 claims
Lilly USA, LLCMounjaro$133$18,18715 claims
GSKTrelegy Ellipta$238$16,78123 claims
PfizerEliquis$150$15,22414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.

Other family in Greeneville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →